Is Cardiovascular drugs and therapy SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

3.58

Citation rate 3.27 749 total citations

h5-index 34 h5 depth signal

Cited share 77.4% 188 of 243

Total citations 749 Citation footprint

Metric signal 3.28 External metric anchor

Self-citation 13.9% 104 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 466

United States 349

United Kingdom 115

Italy 85

Germany 56

Citing Fields of Research

Cardiology 934

Diabetes 195

Lipids 128

Noncoding RNA 66

Physiology 66

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 3,974 Articles tracked across the journal lifetime

Indexed publication set 243 188 cited publications

Last 12 months 175 14.6 publications/month

Open access share 16.0% 28 OA publications in the last year

Leading citing country China 466 citing publications

Leading citing field Cardiology 934 citing publications

Latest tracked publication 17 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v1n1, 1987-

PubMed

v1n1, 1987-

Index medicus

Active Coverage

Research Focus & Classification

Indexed Subjects

Cardiology

Issuing & Sponsoring Bodies

Contributor

International Society of Cardiovascular Pharmacotherapy

Broad Categories

Cardiology Drug Therapy Vascular Diseases

MeSH Descriptors

Cardiovascular Agents Cardiovascular Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 17 October 2026

DOI 10.1007/s10557-026-07977-1

Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism

Open DOI

Miao Miao, Chen Zhikui

02 15 October 2026

DOI 10.1007/s10557-026-07967-3

miR‑18a‑5p Serves as a Diagnostic and Prognostic Biomarker and Attenuates Hypoxia‑Induced Cardiac Microvascular Endothelial Injury by Targeting the HIF1A/NF‑κB Pathway in Chronic Heart Failure

Open DOI

Min-Na Hou, Ying Sun, Rongwen Lin et al.

03 14 October 2026

DOI 10.1007/s10557-026-07980-6

Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial

Open DOI

Jianqi Qiao, Taotao Li

04 14 October 2026

DOI 10.1007/s10557-026-07969-1

MSCs-derived Exosomal miRNA-335-5p Alleviates Apoptosis and Inflammation in Myocardial Infarction by Inhibiting BCL2L11

Open DOI

Chan Wang, Zhou Ji

05 9 October 2026

DOI 10.1007/s10557-026-07963-7

Epac1 Functions as a Central Cardioprotective cAMP Effector During Ischemic and β-adrenergic Preconditioning

Open DOI

M. S. Eriksen, F. E. Ravn, A. Aspevik et al.

Background: β-adrenergic receptor (β-AR) stimulated cAMP signaling may be impaired in pathophysiological conditions such as myocardial ischemia and heart failure, highlighting the need for cardioprotective strategies bypassing β-ARs, dir...

06 9 October 2026

DOI 10.1007/s10557-026-07972-6

Gut Microbiota and Its Metabolites in the Prognosis of Coronary Heart Disease: A Systematic Review and Mechanistic Insights

Open DOI

Weiting Cheng, Guiyang Xia, Huan Xia et al.

07 8 October 2026

DOI 10.1007/s10557-026-07974-4

Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention

Open DOI

Simone Finocchiaro, Luigi Cutore, Costanza Bordonaro et al.

Purpose: Omega-3 polyunsaturated fatty acids lower triglycerides and modulate inflammation, thrombosis, and endothelial function, providing a rationale for their use in cardiovascular prevention. This review examines the influence of for...

08 7 October 2026

DOI 10.1007/s10557-026-07975-3